Former President and Chief Executive Officer · Gossamer Bio, Inc. (GOSS)

Sheila Gujrathi

A named executive officer of Gossamer Bio in every fiscal year CompBrief holds from FY2018 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$7,213,742

Salary $494,000Stock awards $2,757,225

FY2019: $6,245,606

1st of 6 named executive officers at Gossamer Bio by FY2020 total.

6 named officers on file for Gossamer Bio, FY2020

Sheila Gujrathi’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 5 equity grants, each cited to its filing
  • GOSS’s disclosed peer group of 19 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Gossamer Bio’s whole pay program stands against its peers

  • Gossamer Bio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on GOSS→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2021 (DEF 14A).

Free

Get Sheila Gujrathi’s full pay file as a PDF — free

More than this page: up to 10 years of Sheila’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Sheila Gujrathi compensation by year

Gossamer Bio Summary Compensation Table · all 3 fiscal years held
In US dollars, as Gossamer Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020
Salary$469,601$515,398$494,000
Bonus$297,700$314,600$0
Stock awards$17,942,611$0$2,757,225
Option awards$0$5,415,608$3,043,808
Non-equity incentive$0$0$276,676
Pension and deferred compensation$0$0$0
All other$0$0$642,033
Total$18,709,912$6,245,606$7,213,742

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Gossamer Bio, Inc. DEF 14A filed April 27, 2021, accession 0001728117-21-000044, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Gossamer Bio, Inc. filed document, accession 0001728117-21-000044. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2021.

$18.7M
$6.2M
$7.2M
FY18
FY19
FY20
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2019 year-end
TypeUnvested unitsValue at year-endExercise price
RSU553,472$8,650,767—
RSU77,564$1,212,325—
Option380,000—$22.10

Per the Outstanding Equity Awards at Fiscal Year-End table in Gossamer Bio, Inc.'s FY2019 proxy; value at the fiscal year-end close, as the company printed it.

Gossamer Bio’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Sheila Gujrathi · this pageFormer President and Chief Executive Officer$7,213,742
Bryan GiraudoChief Financial Officer$2,014,958
Luisa Salter-CidChief Scientific Officer$1,994,828
Christian WaageExecutive Vice President and General Counsel$1,990,351
Jakob DupontFormer Chief Medical Officer$1,642,287
Faheem HasnainChairman, President and Chief Executive Officer$598,771

The full Gossamer Bio compensation record

free company brief

This page is one person within Gossamer Bio's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Gossamer Bio proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Gossamer Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Sheila Gujrathi's compensation dossier · One-time report. No refunds.